Reading Time: 2 minutesBiomarkers in Oxford (BioMOx) is a research project with the aim of identifying a diagnostic biomarker for MND, which could be used to track the
Search Results for: biomarkers
Reading Time: 3 minutesDr Andrea Malaspina is an Association-funded researcher investigating biomarkers, or ‘biological fingerprints’ of MND. Here he blogs about working with patients and basic science. I
Reading Time: 3 minutesYesterday’s announcement by the biotechnology company Trophos SA of the lack of effectiveness of their compound olesoxime adds to the long list of drugs that
Catching up with the 2024 Poster prize candidates
Reading Time: 6 minutesEvery year, hundreds of research projects from around the world are showcased at the International Symposium, reflecting the sheer amount of research going on in
Celebrating Early Career MND Researchers through the International Symposium on ALS/MND Poster Prize
Reading Time: 5 minutesEach year at the International Symposium, we recognise early career researchers whose work is making exceptional contributions to understanding and treating MND. This prestigious award acknowledges
Reading Time: 5 minutesPrimary Lateral Sclerosis (PLS) is a type of MND that progress slowly over many years. It is estimated that around 3 in 100 people diagnosed
Reading Time: 6 minutesThis year, we are welcoming our 11th cohort of Non-Clinical Research Fellows to our incredible team of more than 320 scientists involved in research grants
Bringing the community together for the 36th International Symposium on ALS/MND
Reading Time: 4 minutesThe International Symposium on ALS/MND has closed its doors once again after three insightful, inspiring and hopeful days! After being postponed in 2020 due to the COVID-19 pandemic, we finally made
Reading Time: 2 minutesThe International Symposium on ALS/MND has closed its doors after three insightful, inspiring and hopeful days! This year’s event in San Diego really has showcased the breadth of research happening around the
Reading Time: 2 minutesThe Preclinical and Prodromal ALS session focused on early diagnosis of MND and the use of biomarkers to reveal early signs of the disease. A key approach to this type of research is to use a